Viewing Study NCT06363006


Ignite Creation Date: 2025-12-26 @ 4:00 PM
Ignite Modification Date: 2025-12-29 @ 7:01 AM
Study NCT ID: NCT06363006
Status: RECRUITING
Last Update Posted: 2024-04-12
First Post: 2024-03-28
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Combination of Cardonizumab Injection and TKI Second Line Therapy for Advanced Hepatocellular Cancer
Sponsor: Peking Union Medical College Hospital
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module